Quick Takeaways: Why It Matters? ECO’s licence of Vaxinano’s late‑stage sheep toxoplasmosis vaccine gives it a low‑cost, de‑risked way to add a high‑value preventative product that directly tackles a major cause of abortion and lamb losses, with peak sales estimated a...
Quick Takeaways: Why It Matters? Medgene’s launch could be a meaningful de-risking event for cattle producers because it creates the first U.S. prescription vaccine option for a parasite with severe herd-level consequences and no approved treatment, potentially reducing losses from mortali...
Quick Takeaways: Why It Matters? The Texas A&M study positions Pictor’s PictVet assay as a highly accurate, non‑invasive tool for monitoring Mycoplasma bovis–associated immune responses in beef cattle, supporting broader use of targeted proteomics in her...
Shots: Why It Matters? Designating Wamego as its global HQ formalizes Axiota’s shift from a product-focused business to an integrated innovation hub, anchoring manufacturing, R&D, and scientific operations in the heart of the KC Animal Health Corridor n...
Tanya: Tell us about your background and what led you to animal health innovation. Jamie: My career has focused on advancing precision molecular technologies, particularly in genomics and targeted protein analysis. I’ve spent more than two decades working at the intersection of science, tr...
